Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
Elucidation of Factors Predicting Efficacy and Toxicity of Post Transplantation Cyclophosphamide (PTCy) as a Strategy for Graft Versus Host Disease Prevention in Haploidentical, Matched Related Donor and Matched Unrelated Donor Peripheral Blood Hematopoietic Cell Transplantation
Sponsor: Atrium Health Levine Cancer Institute
Listed as NCT03555851, this observational or N/A phase trial focuses on Leukemia, Not Otherwise Specified and Leukemia, Other and remains actively recruiting participants. Sponsored by Atrium Health Levine Cancer Institute, it has been updated 27 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
27 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Aug 2025 — Feb 2026 [monthly]
Recruiting
-
Feb 2025 — Aug 2025 [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 22 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Aug 2023 — Feb 2024 [monthly]
Recruiting
Status: Suspended → Recruiting
-
Feb 2023 — Aug 2023 [monthly]
Suspended
-
Nov 2022 — Feb 2023 [monthly]
Suspended
-
Sep 2022 — Nov 2022 [monthly]
Suspended
-
Jul 2022 — Sep 2022 [monthly]
Suspended
-
May 2022 — Jul 2022 [monthly]
Suspended
-
Apr 2022 — May 2022 [monthly]
Suspended
-
Dec 2021 — Apr 2022 [monthly]
Suspended
-
Oct 2021 — Dec 2021 [monthly]
Suspended
-
Sep 2021 — Oct 2021 [monthly]
Suspended
Status: Recruiting → Suspended
-
May 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting · Phase: EARLY_PHASE1 → None
-
Jan 2020 — Sep 2020 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2019 — Jan 2020 [monthly]
Recruiting EARLY_PHASE1
-
May 2019 — Jul 2019 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2019 — May 2019 [monthly]
Recruiting EARLY_PHASE1
-
Aug 2018 — Jan 2019 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Atrium Health Levine Cancer Institute
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .